Connection

Anna Ridolfo to Anti-HIV Agents

Back to Details
This is a "connection" page, showing publications Anna Ridolfo has written about Anti-HIV Agents.
Anna Ridolfo
Connection Strength
0.938
Anti-HIV Agents
  1. Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy. BMC Infect Dis. 2018 Nov 12; 18(1):556.
    View in: PubMed
    Score: 0.302
  2. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older. J Acquir Immune Defic Syndr. 2018 06 01; 78(2):193-201.
    View in: PubMed
    Score: 0.293
  3. Effect of Legal Status on the Early Treatment Outcomes of Migrants Beginning Combined Antiretroviral Therapy at an Outpatient Clinic in Milan, Italy. J Acquir Immune Defic Syndr. 2017 07 01; 75(3):315-321.
    View in: PubMed
    Score: 0.275
  4. Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort. Clin Infect Dis. 2017 May 15; 64(10):1413-1421.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.